Live Breaking News & Updates on Bioway Emergent

There is still no word on when a safety audit by the US Food and Drug Administration will be complete a requirement before the Johnson & Johnson vaccines that were compounded and finished at the Gqeberha-based plant of Aspen Pharmacare can be released into South Africa’s vaccination programme.
South Africa is relying on the delivery of 31 million doses of the single-shot vaccine for its rollout plans. The vaccine has been approved for use by the South African Health Products Regulatory Authority (SAHPRA), with an advisory issued for pregnant and lactating women.
The only other Covid-19 vaccine approved for use in South Africa, and procured by the government is the one made by Pfizer. South Africa has managed to get 30 million doses of this vaccine, but since it requires two shots, there will only be enough for 15 million people. ....

South Africa , Free State , United States , South African , Thobile Mbengashe , Kafi Mojapelo , Zweli Mkhize , Lwazi Manzi , Biosolutions Bayview , Aspen Pharmacare , Popo Maja , Yuven Gounden , Aspen Pharmacare Gqeberha , Janssen Johnson , National Department Of Health , Drug Administration , African Health Products Regulatory Authority , Drug Authority , American Food , Eastern Cape , Sisonke Protocol , Emergent Biosolutions Bayview , Emergent Biosolutions , Health Minister Dr Zweli Mkhize , Alison Hunt , Bioway Emergent ,